Home LiteratureArticle Details
PMID: 12631663 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome.

Gut ·Vol. 52 ·No. 4 ·2003-04-00 ·Pages 523-6

Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, McKendrick MW, Moochhala SM

Abstract

Chronic bowel disturbances resembling irritable bowel syndrome (IBS) develop in approximately 25% of patients after an episode of infectious diarrhoea. Although we have previously shown that psychosocial factors operating at the time of, or prior to, the acute illness appear to predict the development of post-infectious IBS (PI-IBS), our finding of an increased inflammatory cell number in the rectum persisting for at least three months after the acute infection suggested that there is also an organic component involved in the development of PI-IBS. To evaluate this further, we measured expressions of interleukin 1beta (IL-1beta) and its receptor antagonist (IL-1ra) in these patients to provide additional evidence that the pathogenesis of PI-IBS is underpinned by an inflammatory process. Sequential rectal biopsy samples were prospectively obtained during and three months after acute gastroenteritis, from eight patients who developed post-infectious IBS (INF-IBS) and seven patients who returned to normal bowel habits after acute gastroenteritis (infection controls, INF-CON). Eighteen healthy volunteers who had not suffered from gastroenteritis in the preceding two years served as normal controls (NOR-CON). IL-1beta and IL-1ra gene expressions were assayed by reverse transcriptase-polymerase chain reaction, and their levels of expression were quantitated by optical densitometry after electrophoresis on agarose gel. INF-IBS patients exhibited significantly greater expression of IL-1beta mRNA in rectal biopsies than INF-CON patients both during and three months after acute gastroenteritis. Moreover, IL-1beta mRNA expression had increased in biopsies taken from INF-IBS patients at three months after the acute infection but no consistent change was observed in INF-CON patients. IL-1beta mRNA expression of INF-IBS patients at three months post gastroenteritis was significantly greater than NOR-CON whereas that of INF-CON patients was not significantly different from NOR-CON. Despite these differential changes in IL-1beta mRNA expression, no significant changes were observed in IL-1ra mRNA expression among the three groups. These findings indicate that those patients who develop IBS post infection exhibit greater IL-1beta mRNA expression, both during and after the infection, compared with individuals who do not develop PI-IBS. We conclude that such patients may be susceptible to inflammatory stimuli, and that inflammation may play a role in the pathogenesis of PI-IBS.

MeSH Terms
Acute Disease Adult Bacterial Infections/complications,metabolism Colonic Diseases, Functional/metabolism,microbiology Female Gastroenteritis/complications,metabolism Gene Expression Genetic Predisposition to Disease Humans Interleukin 1 Receptor Antagonist Protein Interleukin-1/genetics,metabolism Intestinal Mucosa/metabolism Male Middle Aged Prospective Studies RNA, Messenger/genetics Rectum/metabolism Reverse Transcriptase Polymerase Chain Reaction Sialoglycoproteins/genetics,metabolism
Chemicals
IL1RN protein, human Interleukin 1 Receptor Antagonist Protein Interleukin-1 RNA, Messenger Sialoglycoproteins
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gwee K-A
Department of Medicine, National University Hospital, Singapore. gwee_kok_ann@nus.edu.sg
Collins S M
Read N W
Rajnakova A
Deng Y
Graham J C
McKendrick M W
Moochhala S M
References (23)
23 references, click to expand
  1. The role of psychological and biological factors in postinfective gut dysfunction.
    Gut. 1999 Mar;44(3):400-6 PMID: 10026328
  2. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.
    BMJ. 1999 Feb 27;318(7183):565-6 PMID: 10037630
  3. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis.
    Nat Med. 1999 Oct;5(10):1178-82 PMID: 10502822
  4. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.
    Gut. 2000 Dec;47(6):804-11 PMID: 11076879
  5. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice.
    Gastroenterology. 2001 Jun;120(7):1729-36 PMID: 11375954
  6. The putative role of inflammation in the irritable bowel syndrome.
    Gut. 2001 Dec;49(6):743-5 PMID: 11709500
  7. Activation of the mucosal immune system in irritable bowel syndrome.
    Gastroenterology. 2002 Jun;122(7):1778-83 PMID: 12055584
  8. Evolving pathophysiologic models of functional gastrointestinal disorders.
    Gastroenterology. 2002 Jun;122(7):2032-48 PMID: 12055608
  9. A case for an immunological basis for irritable bowel syndrome.
    Gastroenterology. 2002 Jun;122(7):2078-80 PMID: 12055614
  10. Polymerase chain reaction assay of mRNA using 28S rRNA as internal standard.
    Neurosci Lett. 1992 Nov 23;147(1):114-7 PMID: 1282690
  11. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome.
    Aliment Pharmacol Ther. 2003 Jul 1;18(1):77-84 PMID: 12848628
  12. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.
    Gastroenterology. 1992 Nov;103(5):1587-95 PMID: 1426879
  13. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis.
    Gastroenterology. 1992 Jul;103(1):65-71 PMID: 1535326
  14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  15. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    J Immunol. 1995 Mar 1;154(5):2434-40 PMID: 7868909
  16. Expression of cytokines in the longitudinal muscle myenteric plexus of the inflamed intestine of rat.
    Gastroenterology. 1994 Sep;107(3):691-700 PMID: 8076755
  17. Cytokines in intestinal inflammation: pathophysiological and clinical considerations.
    Gastroenterology. 1994 Feb;106(2):533-9 PMID: 8299918
  18. The role of interleukin-1 in disease.
    N Engl J Med. 1993 Jan 14;328(2):106-13 PMID: 8439348
  19. Psychometric scores and persistence of irritable bowel after infectious diarrhoea.
    Lancet. 1996 Jan 20;347(8995):150-3 PMID: 8544549
  20. Previous inflammation alters the response of the rat colon to stress.
    Gastroenterology. 1996 Dec;111(6):1509-15 PMID: 8942729
  21. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved.
    Am J Physiol. 1997 Jan;272(1 Pt 1):G84-91 PMID: 9038880
  22. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.
    BMJ. 1997 Mar 15;314(7083):779-82 PMID: 9080994
  23. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice.
    Gastroenterology. 1997 Oct;113(4):1224-32 PMID: 9322517
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
2003-04-00
Pages
523-6
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1773606
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com